Hypothetical answer is that the shareholders of LCY Biosciences would own the shares of LCY Biosciences. And nothing changed about that ownership from before to after the transaction (of course). The Change Name provision is standard and simply means that LCY can claim the assets it bought in its own name going forward. It is basically to "phase out" use of the name of the now defunct company. It literally mentions in there that they can use the remaining business cards until their gone, etc, but then its in the name of the purchaser thereafter.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.